Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of the Safety of Ascending Doses of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Normal Healthy Volunteers

NCT00968487 is registered in ClinicalTrials.gov with HemCon Medical Technologies, Inc as lead sponsor.

NCT NCT00968487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00968487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of the Safety of Ascending Doses of Autologous Lyophilized Plasma Versus Fresh Frozen Plasma in Normal Healthy Volunteers
Lead sponsor
HemCon Medical Technologies, Inc
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2011
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy